Yes, Venofer (intravenous iron sucrose) is highly appropriate for this patient with severe iron deficiency.
With a ferritin of 9 µg/L and transferrin saturation of 10%, this patient has clear absolute iron deficiency that warrants intravenous iron therapy. These values are far below any diagnostic threshold for iron deficiency, and the elevated TIBC (491 µg/dL) and transferrin (351 mg/dL) further confirm the body's compensatory response to severe iron depletion 1.
Diagnostic Confirmation
Your patient's iron parameters unequivocally demonstrate iron deficiency:
Ferritin 9 µg/L: This is critically low, well below the diagnostic threshold of <30-45 µg/L used across guidelines 1, 2. Even in inflammatory conditions where ferritin can be falsely elevated, a level this low definitively indicates depleted iron stores.
Transferrin saturation 10%: This is markedly below the <15-20% threshold that defines iron deficiency 2, 3. This indicates insufficient circulating iron available for erythropoiesis.
Elevated TIBC (491 µg/dL) and transferrin (351 mg/dL): These elevated values reflect the body's attempt to capture any available iron, further confirming the deficiency state.
Why Intravenous Iron is Indicated
The 2024 AGA guidelines provide clear direction: intravenous iron should be used if the patient does not tolerate oral iron, ferritin levels do not improve with a trial of oral iron, or the patient has a condition in which oral iron is not likely to be absorbed 1. While you haven't specified whether oral iron was attempted, the severity of this deficiency (ferritin of 9) often warrants proceeding directly to IV iron for several reasons:
Faster repletion: With such profound depletion, oral iron would take months to normalize stores, whereas IV iron can correct deficiency within weeks 4, 5.
Superior efficacy: Multiple studies demonstrate IV iron sucrose produces more rapid and complete restoration of iron stores compared to oral iron 5, 6.
Better tolerability: If oral iron has been tried and failed due to gastrointestinal side effects (common with ferrous sulfate), IV iron avoids these issues 1, 5.
Venofer Dosing and Administration
For iron deficiency anemia in adults, Venofer should be dosed based on calculated iron deficit 7. The FDA label provides specific dosing regimens:
Standard approach: 200 mg IV infusions given 2-3 times weekly until total calculated dose is administered (typically 1000 mg total) 7.
Administration: Dilute in 100 mL normal saline and infuse over 20-30 minutes for 200 mg doses 7.
Monitoring: Observe patient for at least 30 minutes post-infusion for hypersensitivity reactions 7.
Follow-up labs: Recheck CBC and iron parameters (ferritin, TSAT) 4-8 weeks after completing the course 8. Do not check iron studies within 48 hours of last dose as values will be spuriously elevated 7.
Safety Considerations
Venofer has an excellent safety profile when administered appropriately 1. Key precautions include:
Hypersensitivity monitoring: True anaphylaxis is very rare; most reactions are complement activation-related pseudo-allergy (infusion reactions) that respond to slowing the infusion 1, 7.
Hypotension risk: Monitor blood pressure during and after infusion; hypotension may be rate-related 7.
Contraindications: Do not use if patient has known hypersensitivity to iron sucrose, evidence of iron overload, or active bacteremia 9, 7.
Personnel availability: Ensure staff trained in managing hypersensitivity reactions are immediately available 7.
Expected Outcomes
With appropriate IV iron sucrose therapy, you should expect:
Ferritin normalization: Target >50-100 µg/L in absence of inflammation 8, 10.
Symptom improvement: Reduced fatigue, improved exercise tolerance within weeks 12, 6.
Clinical Context Matters
Before proceeding, identify the underlying cause of iron deficiency 1. Common etiologies include:
- Gastrointestinal blood loss (requires endoscopic evaluation)
- Heavy menstrual bleeding in premenopausal women
- Malabsorption (celiac disease, inflammatory bowel disease, post-bariatric surgery)
- Inadequate dietary intake
If the patient has inflammatory bowel disease, chronic heart failure, chronic kidney disease, or post-bariatric surgery, IV iron is particularly indicated as oral absorption is often impaired 1, 9, 13.
Alternative to Oral Iron
If you're considering whether to try oral iron first, the 2024 AGA guidelines state that ferrous sulfate is the preferred oral formulation (least expensive), dosed once daily or every other day, with vitamin C to enhance absorption 1. However, given the severity of this patient's deficiency (ferritin 9), IV iron is the more appropriate initial choice for rapid and reliable repletion.